DESTINY-Breast03 trial: some questions remain
Lancet
.
2023 May 20;401(10389):1653.
doi: 10.1016/S0140-6736(23)00685-2.
Authors
Serena Di Cosimo
1
,
Giovanni Apolone
2
,
Vera Cappelletti
3
,
Valter Torri
4
Affiliations
1
Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy. Electronic address:
[email protected]
.
2
Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
3
Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
4
Laboratory of Methodology for Biomedical Research, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
PMID:
37210116
DOI:
10.1016/S0140-6736(23)00685-2
No abstract available
Publication types
Letter
Comment